173 related articles for article (PubMed ID: 21935446)
1. Structure and behavior of human α-thrombin upon ligand recognition: thermodynamic and molecular dynamics studies.
Silva Vde A; Cargnelutti MT; Giesel GM; Palmieri LC; Monteiro RQ; Verli H; Lima LM
PLoS One; 2011; 6(9):e24735. PubMed ID: 21935446
[TBL] [Abstract][Full Text] [Related]
2. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
3. X-ray crystal structures of thrombin in complex with D-Phe-Pro-Arg and with small benzamidine- and arginine-based "non-peptidic" inhibitors.
Bode W
Adv Exp Med Biol; 1993; 340():15-26. PubMed ID: 8154332
[No Abstract] [Full Text] [Related]
4. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.
Bode W; Turk D; Karshikov A
Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349
[TBL] [Abstract][Full Text] [Related]
5. New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK.
Martin PD; Malkowski MG; Box J; Esmon CT; Edwards BF
Structure; 1997 Dec; 5(12):1681-93. PubMed ID: 9438869
[TBL] [Abstract][Full Text] [Related]
6. Correlated motions and residual frustration in thrombin.
Fuglestad B; Gasper PM; McCammon JA; Markwick PR; Komives EA
J Phys Chem B; 2013 Oct; 117(42):12857-63. PubMed ID: 23621631
[TBL] [Abstract][Full Text] [Related]
7. Thrombomodulin Binding Selects the Catalytically Active Form of Thrombin.
Handley LD; Treuheit NA; Venkatesh VJ; Komives EA
Biochemistry; 2015 Nov; 54(43):6650-8. PubMed ID: 26468766
[TBL] [Abstract][Full Text] [Related]
8. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin.
Arni RK; Padmanabhan K; Padmanabhan KP; Wu TP; Tulinsky A
Biochemistry; 1993 May; 32(18):4727-37. PubMed ID: 8387813
[TBL] [Abstract][Full Text] [Related]
9. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. I. Specificity of thrombin labeling.
Bock PE
J Biol Chem; 1992 Jul; 267(21):14963-73. PubMed ID: 1634535
[TBL] [Abstract][Full Text] [Related]
10. Proton bridging in the interactions of thrombin with small inhibitors.
Kovach IM; Kelley P; Eddy C; Jordan F; Baykal A
Biochemistry; 2009 Aug; 48(30):7296-304. PubMed ID: 19530705
[TBL] [Abstract][Full Text] [Related]
11. Activation of platelets by alpha-thrombin is a receptor-mediated event. D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone-thrombin, but not N alpha-tosyl-L-lysine chloromethyl ketone-thrombin, binds to the high affinity thrombin receptor.
Harmon JT; Jamieson GA
J Biol Chem; 1986 Dec; 261(34):15928-33. PubMed ID: 3023333
[TBL] [Abstract][Full Text] [Related]
12. Allosteric changes in solvent accessibility observed in thrombin upon active site occupation.
Croy CH; Koeppe JR; Bergqvist S; Komives EA
Biochemistry; 2004 May; 43(18):5246-55. PubMed ID: 15122890
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
Odake S; Kam CM; Powers JC
J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
[TBL] [Abstract][Full Text] [Related]
14. PPACK-thrombin is a noncompetitive inhibitor of alpha-thrombin binding to human platelets.
Schmaier AH; Meloni FJ; Nawarawong W; Jiang YP
Thromb Res; 1992 Sep; 67(5):479-89. PubMed ID: 1448784
[TBL] [Abstract][Full Text] [Related]
15. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases.
Bock PE
J Biol Chem; 1992 Jul; 267(21):14974-81. PubMed ID: 1634536
[TBL] [Abstract][Full Text] [Related]
16. Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.
Bock PE
Biochemistry; 1988 Aug; 27(17):6633-9. PubMed ID: 3219359
[TBL] [Abstract][Full Text] [Related]
17. Crystallographic determination of the structures of human alpha-thrombin complexed with BMS-186282 and BMS-189090.
Malley MF; Tabernero L; Chang CY; Ohringer SL; Roberts DG; Das J; Sack JS
Protein Sci; 1996 Feb; 5(2):221-8. PubMed ID: 8745399
[TBL] [Abstract][Full Text] [Related]
18. The structure of a designed peptidomimetic inhibitor complex of alpha-thrombin.
Wu TP; Yee V; Tulinsky A; Chrusciel RA; Nakanishi H; Shen R; Priebe C; Kahn M
Protein Eng; 1993 Jul; 6(5):471-8. PubMed ID: 8415574
[TBL] [Abstract][Full Text] [Related]
19. Immobilization of the irreversible thrombin inhibitor D-Phe-Pro-Arg-chloromethylketone: a concept for hemocompatible surfaces?
Maitz MF; Sperling C; Werner C
J Biomed Mater Res A; 2010 Sep; 94(3):905-12. PubMed ID: 20730927
[TBL] [Abstract][Full Text] [Related]
20. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
Mosesson MW; Hernandez I; Siebenlist KR
Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]